Sharon Hesterlee's Blog – January 2013 Archive (1)

Sarepta Summary of Outstanding Questions from PPMD Webinar

On October 23, 2012, PPMD hosted a webinar with Sarepta to discuss of the 48 Week dystrophin and 6-minute walk test (6MWT) data from the Phase IIb extension study in Duchenne as well as next steps for the eteplirsen program. Chris Garabedian, President and CEO of Sarepta…


Added by Sharon Hesterlee on January 17, 2013 at 12:00pm — No Comments

Need help using this community site? Visit Ning's Help Page.



© 2021   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service